[go: up one dir, main page]

PL3353191T3 - Cykliczne polipeptydy, sposób ich pozyskiwania oraz ich zastosowanie terapeutyczne - Google Patents

Cykliczne polipeptydy, sposób ich pozyskiwania oraz ich zastosowanie terapeutyczne

Info

Publication number
PL3353191T3
PL3353191T3 PL16794681.3T PL16794681T PL3353191T3 PL 3353191 T3 PL3353191 T3 PL 3353191T3 PL 16794681 T PL16794681 T PL 16794681T PL 3353191 T3 PL3353191 T3 PL 3353191T3
Authority
PL
Poland
Prior art keywords
polypeptides
obtaining
therapeutic use
cyclic
cyclic polypeptides
Prior art date
Application number
PL16794681.3T
Other languages
English (en)
Inventor
Dominique Bridon
Stéphane GOBRON
Original Assignee
Axoltis Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axoltis Pharma filed Critical Axoltis Pharma
Publication of PL3353191T3 publication Critical patent/PL3353191T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL16794681.3T 2015-09-25 2016-09-23 Cykliczne polipeptydy, sposób ich pozyskiwania oraz ich zastosowanie terapeutyczne PL3353191T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1559084A FR3041644B1 (fr) 2015-09-25 2015-09-25 Polypeptides cycliques, leur procede d'obtention et leur application en therapeutique
PCT/FR2016/052422 WO2017051135A1 (fr) 2015-09-25 2016-09-23 Polypeptides cycliques, leur procede d'obtention et leur application en therapeutique

Publications (1)

Publication Number Publication Date
PL3353191T3 true PL3353191T3 (pl) 2023-10-30

Family

ID=54545335

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16794681.3T PL3353191T3 (pl) 2015-09-25 2016-09-23 Cykliczne polipeptydy, sposób ich pozyskiwania oraz ich zastosowanie terapeutyczne

Country Status (12)

Country Link
US (1) US10501497B2 (pl)
EP (1) EP3353191B1 (pl)
JP (1) JP6998878B2 (pl)
KR (1) KR102806029B1 (pl)
CN (1) CN108350035A (pl)
AU (1) AU2016328916B2 (pl)
CA (1) CA2999797A1 (pl)
DK (1) DK3353191T3 (pl)
ES (1) ES2952519T3 (pl)
FR (1) FR3041644B1 (pl)
PL (1) PL3353191T3 (pl)
WO (1) WO2017051135A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3330284A1 (en) * 2016-12-05 2018-06-06 Neuronax Sa Use of peptide compounds for promoting survival, growth and cell differentiation
EP3360884A1 (en) 2017-02-10 2018-08-15 Neuronax Improved process for the preparation of a dodecapeptide
JP7609858B2 (ja) * 2019-10-07 2025-01-07 アクソルティス・ファーマ 脊髄損傷の治療のため及び／又は髄鞘再形成のためのペプチドの全身投与
EP4069273A1 (en) * 2019-12-05 2022-10-12 Axoltis Pharma Peptide compositions and methods for treating tauopathies
JP2024525594A (ja) 2021-07-09 2024-07-12 アクソルティス・ファーマ シナプス伝達を増進させるためのｓｃｏ－スポンジン由来ポリペプチド
EP4190347A1 (en) 2021-12-01 2023-06-07 Axoltis Pharma Sco-spondin-derived polypeptides for treating biological barriers dysfunction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1069137A1 (en) * 1990-09-24 2001-01-17 W.R. Grace & Co.-Conn. Peptides having thrombospondin-like activity and their therapeutic use
FR2766190B1 (fr) 1997-07-16 2001-11-02 Univ Clermont Auvergne Nouveaux peptides et polypeptides utiles dans la regeneration du systeme nerveux
FR2910003B1 (fr) 2006-12-18 2012-10-26 Neuronax Nouveaux peptides et polypeptides a stabilite amelioree utiles dans la regeneration du systeme nerveux
EP2027868A1 (en) 2007-08-24 2009-02-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of SCO-Spondin peptides for inhibiting or preventing neuronal apoptosis mediated by cell death receptor ligands
JP5476538B2 (ja) * 2008-03-31 2014-04-23 学校法人 久留米大学 肝疾患に伴う浮腫の判定方法
JP2014101274A (ja) 2011-03-09 2014-06-05 Jitsubo Co Ltd 新規な架橋構造を含むｔｎｆレセプターループペプチドの模倣ペプチドを用いた医薬組成物
US9897611B2 (en) 2012-12-27 2018-02-20 National Institute Of Advanced Industrial Science And Technology Molecule library constructed on the basis of backbone structure of microprotein
WO2014115229A1 (ja) 2013-01-28 2014-07-31 独立行政法人産業技術総合研究所 抗体結合性ペプチド

Also Published As

Publication number Publication date
FR3041644A1 (fr) 2017-03-31
FR3041644B1 (fr) 2018-01-05
KR20180050755A (ko) 2018-05-15
CN108350035A (zh) 2018-07-31
DK3353191T3 (da) 2023-08-14
JP2018531284A (ja) 2018-10-25
AU2016328916B2 (en) 2020-08-20
ES2952519T3 (es) 2023-10-31
US20180265549A1 (en) 2018-09-20
EP3353191A1 (fr) 2018-08-01
KR102806029B1 (ko) 2025-05-09
US10501497B2 (en) 2019-12-10
CA2999797A1 (fr) 2017-03-30
JP6998878B2 (ja) 2022-01-18
AU2016328916A1 (en) 2018-04-19
WO2017051135A1 (fr) 2017-03-30
EP3353191B1 (fr) 2023-05-24

Similar Documents

Publication Publication Date Title
PT3546457T (pt) Derivado de pirazolo-heteroarílico, método de preparação e a utilização médica do mesmo
PL3486242T3 (pl) Pochodna oksopikolinamidu, sposób jej wytwarzania i zastosowanie farmaceutyczne
IL249370A0 (en) Fap-enabled medical substances and related uses
SG11201608711RA (en) Material itq-55, method for preparation and use
SG11201607924TA (en) Figure, platform, and figure system
IL262824A (en) Method, array and their uses
GB2588261B (en) Apparatus, use of the apparatus and arrangement
SG11201703831YA (en) Itinerary determination method, itinerary determination program and itinerary determination device
SG11201708624YA (en) Therapeutic antibodies and uses thereof
PL3157901T3 (pl) Preparaty, ich wytwarzanie i zastosowanie, oraz odpowiednie składniki
GB201516801D0 (en) Method, array and use thereof
SG11201703631VA (en) Novel carbodiimides, method for the production and use thereof
GB201408673D0 (en) Medicaments,uses and methods
GB201405784D0 (en) Novel methods, polypeptides and uses thereof
GB201410108D0 (en) Peptides, and methods and apparatus utilising same
PL3353191T3 (pl) Cykliczne polipeptydy, sposób ich pozyskiwania oraz ich zastosowanie terapeutyczne
IL257434A (en) Mrka polypeptides, antibodies, and uses thereof
IL258056A (en) Foxm1-derived peptide and a component containing it
PT3350150T (pt) 1,1-difeniletilenos substituídos por alcenilfenoxilo, processos para a sua preparação e sua utilização
ZA201707371B (en) Cannula device, artificial lung
PL3386988T3 (pl) Nowe pochodne dihydropiranopirymidynonu i ich zastosowanie
ZA201907335B (en) Benzothiazole-containing silanes, method for the preparation and use thereof
GB201717345D0 (en) Peptides, methods and apparatus
IL258107A (en) Peptide derivative - mphosph1 and a component containing it
GB2554461B (en) But-2-ene-1,4-diols and methods for the preparation thereof